17 material Form 8-K filings that 16 companies we cover made with the SEC in May 2023, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
On May 21, 2023, Krystal Biotech agreed to sell 1,729,729 shares of common stock to institutional investors at $92.50 per share, for an aggregate purchase price of approximately $160 million before offering expenses. The company plans to use the proceeds for commercialization of VYJUVEK, its clinical pipeline, business development, and working capital, and expects the sale to close on May 22, 2023. The new shares add to the company's outstanding share count, which dilutes existing shareholders, while the company says the funds should support operations through the end of 2026.
1,729,729 shares of common stock to be sold at $92.50 per share, for approximately $160 million in gross proceeds before offering-related expenses
Agreement dated May 21, 2023; closing expected May 22, 2023, subject to customary conditions
Financing led by Avoro Capital Advisors and Redmile Group, LLC, with participation from Braidwell LP and Frazier Life Sciences
Company agreed to file a registration statement for resale of the shares within 60 days of closing
Galata Acquisition Corp. (SPAC) and Marti Technologies amended their business combination agreement on April 28, 2023, removing a $50,000,000 cash closing condition and extending the outside date to July 31, 2023. The companies also amended convertible note subscriptions covering $35,500,000 of principal, raising the conversion premium to 15.0% from 10.0% and adding monthly reset dates, which could affect share dilution for existing holders.
April 28, 2023: BCA Amendment No. 1 removes the $50,000,000 SPAC cash-on-hand closing condition and extends the outside date to July 31, 2023.
PIPE Amendment covers convertible notes with $35,500,000 aggregate principal and removes PIPE investor lock-up restrictions.
Revised Indenture raises the conversion premium to 15.0% and provides for monthly reset dates over the first twelve months after issuance.
May 4, 2023: Farragut Square Global Master Fund, an affiliate of a SPAC director, may subscribe for up to $40,000,000 of convertible notes after closing.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.